Validity of self-report of infections in a longitudinal cohort of patients with rheumatoid arthritis differs by source of report and infection severity

This publication has 8 references indexed in Scilit:

• Post-marketing Strategies for Medicines
  Clinical Pharmacology & Therapeutics, 2007
• Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists
  Annals of the Rheumatic Diseases, 2007
• Veteran's affairs hospital discharge databases coded serious bacterial infections accurately
  Journal of Clinical Epidemiology, 2007
• Confirmation of administrative claims‐identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor α antagonists and disease‐modifying antirheumatic drugs
  Arthritis Care & Research, 2007
• Rates of serious infection, including site‐specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti–tumor necrosis factor therapy: Results from the British Society for Rheumatology Biologics Register
  Arthritis & Rheumatism, 2006
• Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies
  JAMA, 2006
• Infections during low-dose methotrexate treatmentin rheumatoid arthritis
  Seminars in Arthritis and Rheumatism, 1995
• Infection rate and use of antibiotics in patients with rheumatoid arthritis treated with methotrexate.
  Annals of the Rheumatic Diseases, 1994